The Food and Drug Administration (FDA) will allow Juul Labs' vaping products to remain on the market for now, according to the New York Times. The reprieve comes after the FDA ordered Juul to stop selling its vaping products in the U.S. on June 23. The U.S. Court of Appeals for the D.C. Circuit issued an administrative stay of the order the following day. The FDA has announced that it will conduct an internal review of the initial ban, and stipulated that the order had only been paused — not rescinded.
Related Posts
Acid reflux, migraines linked
A new study suggests a link between taking acid reflux medications and risk of migraines. Researchers, writing in the journal Neurology Clincal Practice,…
Brave hearts: Moon landing by the beat
It is 1969, on the Saturn V launch pad, as three astronauts sit atop a 300-foot rocket loaded with a liquid hydrogen bomb. The average resting heart rate…
Cyberattacks hit medical records
Electronic health records (EHRs) are the most valuable type of stolen personal data, according to the U.S. Department of Health and Human Services (HHS)…